PRESCRIBING · PART D · 2024
Total Rx claims
301
Beneficiaries
—
Total drug cost
$449K
Distinct drugs
13
Brand share
32.2%
Top prescribed drugs
Imipenem/Cilastatin Sodium46 claims
Ethambutol Hcl38 claims
Azithromycin37 claims
Tigecycline35 claims
Rifabutin25 claims
QUALITY · MIPS · 2024
Final MIPS score
47.5
Quality
38.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
-3.30%
APM Entity
CROSS-REFERENCE